(0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

メニュー 戻る 03

Track 3: Data, Technology and AI

This track explores end-to-end strategies for designing and executing high-quality, efficient, and globally scalable clinical trials. It brings together global voices such as regulators, industry, academia, and patients, offering cross-disciplinary perspectives and emphasizing global harmonization of effort to address the most urgent operational and delivery challenges in modern clinical trials. Sessions highlight operational excellence, project management frameworks, technology-enabled solutions, and inclusive approaches that improve trial delivery from start-up through close-out. Attendees will gain insights into best practices for optimizing trial execution, managing vendors and partners, and ensuring operational readiness for increasingly complex trial designs.

  • Practical Applications of AI in Drug Development: Leveraging AI/ML for data generation, trial design optimization, predictive modeling, and regulatory submissions
  • Real-World Evidence (RWE) for Development and Post-Market Use: Generating, curating, and integrating RWE to inform clinical development, regulatory decision-making, and health technology assessments (HTAs)
  • Digital Health Technologies and Decentralized Trials: Lessons learned from DHT adoption, wearables, mobile apps, and approaches to scaling decentralized and hybrid trial solutions
  • Data Standards and Interoperability: Driving multi-stakeholder collaboration through standardized data frameworks, ensuring quality, integrity, and cross-border data sharing
  • Policy-Driven Innovation, Ethics, and Digital Equity: Understanding evolving policy frameworks for data use, ensuring information access and equity, and addressing cybersecurity, privacy, and responsible AI adoption
  • Transformation of Translational Science through Data Integration: Leveraging big data and advanced analytics to accelerate translational research and connect preclinical and clinical insights
  • Democratizing Patient Experience Data (PED) through AI and Digital Innovations: Exploring how advanced analytics, AI, and digital platforms can capture, democratize, and operationalize patient experience data to inform trial design, regulatory submissions, post-market decision-making, and equitable access to therapies
  • Clinical Data Management and Enablement: Best practices and innovations in trial data capture, curation, cleaning, standardization, and integration to ensure high-quality datasets for regulatory submissions, RWE generation, and decision-making
  1. How can AI and advanced analytics be practically applied to optimize clinical trial design, streamline development processes, and support regulatory decision-making?
  2. What best practices and lessons learned from digital health technologies (DHTs) and decentralized trial solutions can be scaled to improve patient access, engagement, and data quality?
  3. How can real-world evidence (RWE) and integrated data sources be effectively generated, curated, and applied in both development and post-market settings to inform regulatory submissions, safety monitoring, and healthcare decision-making?
  4. What data standards, interoperability frameworks, and policy-driven innovations are needed to ensure equitable information access, secure data sharing, and seamless collaboration across stakeholders globally?

Browse Related eLearning Courses

Registration Rates

Back to DIA 2026

Back to DIAglobal.org

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。